|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 4 (February 15), 1999:
pp. 1330-1337
Molecular Analysis of 11q13 Breakpoints in Multiple Myeloma
Domenica Ronchetti,
Palma Finelli,
Raffaella Richelda,
Luca Baldini,
Mariano Rocchi,
Luigi Viggiano,
Antonio Cuneo,
Silvia Bogni,
Sonia Fabris,
Luigia Lombardi,
Anna Teresa Maiolo, and
Antonino Neri
From the Laboratorio di Ematologia Sperimentale e Genetica
Molecolare, Servizio di Ematologia, Università degli Studi di
Milano, Ospedale Maggiore IRCCS, Milano; Istituto di Genetica,
Università di Bari, Bari; and Dipartimento di Scienze Biomediche
e Terapie Avanzate, Università di Ferrara, Ferrara, Italy.
The t(11;14)(q13;q32) chromosomal translocation, which is the
hallmark of mantle cell lymphoma (MCL), is found in approximately 30%
of multiple myeloma (MM) tumors with a 14q32 translocation. Although
the overexpression of cyclin D1 has been found to be correlated
with MM cell lines carrying the t(11;14), rearrangements of the
BCL-1/cyclin D1 regions frequently involved in MCL
rarely occur in MM cell lines or primary tumors. To test whether
specific 11q13 breakpoint clusters may occur in MM, we investigated a
representative panel of primary tumors by means of Southern blot
analysis using probes derived from MM-associated 11q13 breakpoints. To
this end, we first cloned the breakpoints and respective germ-line
regions from a primary tumor and the U266 cell line, as well as the
germ-line region from the KMS-12 cell line. DNA from 50 primary tumors
was tested using a large panel of probes, but a rearrangement was detected in only one case using the KMS-12 breakpoint probe. Our results confirm previous findings that the 11q13 breakpoints in MM are
scattered throughout the 11q13 region encompassing the cyclin
D1 gene, thus suggesting the absence of 11q13 breakpoint clusters in MM.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. Cirello, M. P. Recalcati, M. Muzza, S. Rossi, M. Perrino, L. Vicentini, P. Beck-Peccoz, P. Finelli, and L. Fugazzola
Fetal Cell Microchimerism in Papillary Thyroid Cancer: A Possible Role in Tumor Damage and Tissue Repair
Cancer Res.,
October 15, 2008;
68(20):
8482 - 8488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Mao, S.-b. Liang, R. Hurren, M. Gronda, S. Chow, G. W. Xu, X. Wang, R. B. Zavareh, N. Jamal, H. Messner, et al.
Cyproheptadine displays preclinical activity in myeloma and leukemia
Blood,
August 1, 2008;
112(3):
760 - 769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Agnelli, S. Bicciato, M. Mattioli, S. Fabris, D. Intini, D. Verdelli, L. Baldini, F. Morabito, V. Callea, L. Lombardi, et al.
Molecular Classification of Multiple Myeloma: A Distinct Transcriptional Profile Characterizes Patients Expressing CCND1 and Negative for 14q32 Translocations
J. Clin. Oncol.,
October 10, 2005;
23(29):
7296 - 7306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Stromberg, A. Dimberg, A. Hammarberg, K. Carlson, A. Osterborg, K. Nilsson, and H. Jernberg-Wiklund
Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone
Blood,
April 15, 2004;
103(8):
3138 - 3147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Fonseca, B. Barlogie, R. Bataille, C. Bastard, P. L. Bergsagel, M. Chesi, F. E. Davies, J. Drach, P. R. Greipp, I. R. Kirsch, et al.
Genetics and Cytogenetics of Multiple Myeloma: A Workshop Report
Cancer Res.,
February 15, 2004;
64(4):
1546 - 1558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Soverini, M. Cavo, C. Cellini, C. Terragna, E. Zamagni, D. Ruggeri, N. Testoni, P. Tosi, A. de Vivo, M. Amabile, et al.
Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation
Blood,
September 1, 2003;
102(5):
1588 - 1594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Specht, M. Kremer, U. Muller, S. Dirnhofer, M. Rosemann, H. Hofler, L. Quintanilla-Martinez, and F. Fend
Identification of Cyclin D1 mRNA Overexpression in B-Cell Neoplasias by Real-Time Reverse Transcription-PCR of Microdissected Paraffin Sections
Clin. Cancer Res.,
September 1, 2002;
8(9):
2902 - 2911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Perfetti, A. M. L. Coluccia, D. Intini, U. Malgeri, M. C. Vignarelli, S. Casarini, G. Merlini, and A. Neri
Translocation t(4;14)(p16.3;q32) Is a Recurrent Genetic Lesion in Primary Amyloidosis
Am. J. Pathol.,
May 1, 2001;
158(5):
1599 - 1603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Malgeri, L. Baldini, V. Perfetti, S. Fabris, M. C. Vignarelli, G. Colombo, V. Lotti, S. Compasso, S. Bogni, L. Lombardi, et al.
Detection of t(4;14)(p16.3;q32) Chromosomal Translocation in Multiple Myeloma by Reverse Transcription-Polymerase Chain Reaction Analysis of IGH-MMSET Fusion Transcripts
Cancer Res.,
August 1, 2000;
60(15):
4058 - 4061.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Pruneri, S. Fabris, L. Baldini, N. Carboni, S. Zagano, M. A. Colombi, G. Ciceri, L. Lombardi, M. Rocchi, R. Buffa, et al.
Immunohistochemical Analysis of Cyclin D1 Shows Deregulated Expression in Multiple Myeloma with the t(11;14)
Am. J. Pathol.,
May 1, 2000;
156(5):
1505 - 1513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. G. Janssen, J.-W. Vaandrager, T. Heuser, A. Jauch, P. M. Kluin, E. Geelen, P. L. Bergsagel, W. M. Kuehl, H. G. Drexler, T. Otsuki, et al.
Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32)
Blood,
April 15, 2000;
95(8):
2691 - 2698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Macintyre, D. Willerford, and S. W. Morris
Non-Hodgkin's Lymphoma: Molecular Features of B Cell Lymphoma
Hematology,
January 1, 2000;
2000(1):
180 - 204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Finelli, S. Fabris, S. Zagano, L. Baldini, D. Intini, L. Nobili, L. Lombardi, A. T. Maiolo, and A. Neri
Detection of t(4;14)(p16.3;q32) Chromosomal Translocation in Multiple Myeloma by Double-Color Fluorescent In Situ Hybridization
Blood,
July 15, 1999;
94(2):
724 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Casanovas, F. Miro, J. M. Estanyol, E. Itarte, N. Agell, and O. Bachs
Osmotic Stress Regulates the Stability of Cyclin D1 in a p38SAPK2-dependent Manner
J. Biol. Chem.,
November 3, 2000;
275(45):
35091 - 35097.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|